We describe here the development, optimization, and use of a nonradioactive, quantitative, multiplex reverse transcriptase-PCR technique to measure, in a single reaction, the relative levels of the transcripts of four DNA repair genes (XPCC, hMSH2, XRCC1, and ERCC1) and the β-actin gene in lymphoblastoid cell lines and frozen peripheral blood lymphocytes. Expression of defective DNA repair genes was not detected in DNA repair-deficient human cell lines, whereas the intact genes were detected in repair-proficient cell lines and in lymphocytes from a normal donor. The assay was reproducible, and repeated determinations of the same samples generated highly consistent results for each target gene. This approach should facilitate molecular epidemiological studies that incorporate screening for germline alterations that may affect gene expression and for changes in the levels of gene expression.


This work was supported in part by National Cancer Institute Grant CA16672 to M. D. Anderson Cancer Center and in part by an institutional start-up fund to Q. W. Part of this work was presented at the annual meeting of the American Society of Preventive Oncology in Houston, Texas, on March 9–11, 1995.

This content is only available via PDF.